Sergi C, Consalez G G, Fabbretti G, Brisigotti M, Faa G, Costa V, Romeo G, Callea F
Department of Pathology, G. Gaslini Genova Children's Hospital, Italy.
Lab Invest. 1994 Jan;70(1):130-3.
Genetic alpha-1-antitrypsin (AAT) deficiency may be due to defective secretion, intracellular degradation, or lack of synthesis. Defective secretion results in hepatocytic storage and liver disease. These two events occur only with the common deficiency variant, Z AAT, and with a few rare deficiency variants, called M-like. Hepatocytic storage of AAT (either Z or M-like) can be demonstrated in tissue sections by specific immunostaining with a polyclonal anti-AAT antibody, that recognizes all variants of AAT. A monoclonal antibody capable of selectively and exclusively reacting with Z AAT has been generated and successfully used in both serum and tissue studies.
To determine whether a new M-like variant, M Cagliari, carries a mutation different from Z AAT, we have compared antigenic properties and DNA sequences of the two variants. Liver tissue sections from PiZ and PiM Cagliari patients were stained with both polyclonal anti-AAT and monoclonal anti-Z AAT antibodies. DNAs were polymerase chain reaction-amplified with AAT-specific primers and sequenced.
Liver tissue sections from PiZ livers were positively stained with either the polyclonal or the monoclonal antibody. The PiM Cagliari liver sections reacted with the polyclonal antibody, but not with the monoclonal anti-Z AAT, thus indicating a difference in antigenicity from Z AAT. Accordingly, DNA analysis ruled out a Z mutation and revealed a microdeletion in exon II, identical with M Malton.
A simple immunohistochemical assay based upon the application of both polyclonal and monoclonal antibodies represents a reliable test to distinguish Z and nonZ AAT deficiencies, thus assisting in the selection of cases worthy of more time-consuming analyses such as DNA sequencing. The same approach may be used for the characterization of as yet undefined PiM cases with AAT liver storage.
遗传性α-1-抗胰蛋白酶(AAT)缺乏可能是由于分泌缺陷、细胞内降解或合成不足所致。分泌缺陷会导致肝细胞内储存和肝脏疾病。这两种情况仅在常见的缺陷变体Z AAT以及少数罕见的缺陷变体(称为M样变体)中出现。通过使用能识别所有AAT变体的多克隆抗AAT抗体进行特异性免疫染色,可在组织切片中显示AAT(Z或M样)在肝细胞内的储存情况。一种能够选择性且仅与Z AAT反应的单克隆抗体已被研制出来,并成功应用于血清和组织研究。
为了确定一种新的M样变体M Cagliari是否携带与Z AAT不同的突变,我们比较了这两种变体的抗原特性和DNA序列。来自PiZ和PiM Cagliari患者的肝组织切片用多克隆抗AAT抗体和单克隆抗Z AAT抗体进行染色。DNA用AAT特异性引物进行聚合酶链反应扩增并测序。
PiZ肝脏的肝组织切片用多克隆抗体或单克隆抗体染色均呈阳性。PiM Cagliari肝组织切片与多克隆抗体反应,但不与单克隆抗Z AAT反应,这表明其抗原性与Z AAT不同。相应地,DNA分析排除了Z突变,并揭示外显子II存在一个微缺失,与M Malton相同。
基于多克隆抗体和单克隆抗体联合应用的简单免疫组织化学检测是区分Z型和非Z型AAT缺乏的可靠检测方法,有助于选择值得进行更耗时分析(如DNA测序)的病例。同样的方法可用于鉴定尚未明确的伴有AAT肝脏储存的PiM病例。